[HTML][HTML] The efficacy and safety of gefapixant in a phase 3b trial of patients with recent-onset chronic cough

L McGarvey, M Sher, YG Shvarts, S Lu, WC Wu, P Xu… - Lung, 2023 - Springer
Purpose We evaluated gefapixant, a P2X3 receptor antagonist, in participants with recent-onset
(≤ 12 months) refractory chronic cough (RCC) or unexplained chronic cough (UCC). …

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a …

T Kharitonova, YG Shvarts, AF Verbovoy… - BMJ Open Diabetes …, 2022 - drc.bmj.com
Introduction Antioxidants may have positive impact on diabetic polyneuropathy (DPN),
presumably due to alleviation of oxidative stress. We aimed to evaluate the efficacy and safety of …

[HTML][HTML] The severity of chronic heart failure and the parameters of daily blood pressure profile in patients with coronary heart disease

NS Akimova, YG Shvarts, ND Mikhel… - Exploration of …, 2024 - explorationpub.com
Aim: Although the prevalence of coronary heart disease (CHD) and hypertension which are
the most common causes of the development and progression of chronic heart failure (CHF) …

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia

…, S Bonora, A Saffoury, A Mayo, Y Shvarts… - medRxiv, 2022 - medrxiv.org
Rationale There are few treatment options for severe COVID-19 pneumonia. Opaganib is an
oral treatment under investigation. Objective Evaluate opaganib treatment in hospitalized …

[BOOK][B] Becoming an Andegraund Poet: Elena Shvarts and the Literary Environment of the Late Soviet Era

LL Little - 2021 - search.proquest.com
… Studying Shvarts’s strategies for self-realization enhances … the literary environment in which
Shvarts came of age, presenting … Chapter One describes Shvarts’s origins and arrival on the …

Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized …

…, EA Orlova, RF Khamitov, YG Shvarts… - Terapevticheskii …, 2022 - ter-arkhiv.ru
Background. A multicenter, double-blind, placebo-controlled, randomized clinical trial (RCT)
of the phase III efficacy and safety of Ergoferon® for the non-specific prevention of COVID-…

[HTML][HTML] Comparison of the efficacy and safety of ketoprofen plaster and diclofenac plaster for osteoarthritis-related knee pain: A multicenter, randomized, active …

S Yakushin, S Polyakova, Y Shvarts, A Kastanayan… - Clinical Therapeutics, 2021 - Elsevier
Purpose To compare the efficacy and safety of ketoprofen plasters and diclofenac plasters
after 3 weeks of administration in patients with osteoarthritis-related knee pain. Methods This …

[PDF][PDF] Measures of chronic heart failure as the markers of cognitive dysfunction in patients with coronary heart disease complicated by circulatory failure

NS Akimova, OV Bugaeva, LE Konshina, YG Shvarts - system, 2021 - e-coretvasa.cz
Objective: To study the relationship between the cerebral morpho-functional changes and
left ventricular ejection fraction and functional class of chronic heart failure. Materials and …

[HTML][HTML] Transient Hypotension in Elderly Hypertensive Patients: What and How to Manage?

SA Ermasova, YG Shvarts - eJ. Cardiol. Pract., 2022 - escardio.org
Hypertension treatment in the elderly population should be aimed not only at achieving target
pressures, but also at preventing transient hypotensive episodes. This is especially true for …

The effect of etiopathogenetic therapy of COVID-19 on the severity of the disease: results of a multicenter double-blind placebo-controlled randomized trial

…, AA Stremoukhov, MG Avdeeva, YG Shvarts… - Terapevticheskii …, 2023 - ter-arkhiv.ru
Aim. The search for etiopathogenetic agents to prevent the development of severe and
extremely severe COVID-19 remains relevant. A placebo-controlled randomized clinical trial was …